MedTrace Logo

Effectiveness of the Iconic Therapy for Borderline Personality Disorder Symptoms

NCT03011190 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2018-05-15

No results posted yet for this study

Summary

Borderline personality disorder (BPD) is the most prevalent personality disorder in young community population whose most severe complication is suicide. Pharmacotherapy should not be used as the primary treatment for BPD as the benefits are unclear. Psychotherapy is the main treatment for people with BPD and the current recommendation is adapting available comprehensive treatments to develop easier and briefer therapies that are also effective. Iconic Therapy is an innovative option whose good clinical results should be validated on a clinical trial.

Conditions

  • Personality Disorder, Borderline

Interventions

BEHAVIORAL

Emotional regulation

Educate people with difficulty in regulating their emotions and help them acquire skills to do so

Sponsors & Collaborators

  • Silvia Elisa Hurtado Santiago

    lead OTHER

Principal Investigators

  • Rosa Bersabé, Psychologist · Malaga University

  • Fermín Mayoral, Psychiatrist · Hospital Regional de Malaga

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2017-07-31
Completion
2017-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03011190 on ClinicalTrials.gov